Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-10

Clinical Trial Update: Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults with Recurrent Medulloblastoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase study examining intraventricular infusion of panobinostat (MTX110) into the fourth ventricle for recurrent medulloblastoma in children and adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Panobinostat (MTX110) (panobinostat)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Medulloblastoma | EARLY_Phase 1 | Status: COMPLETED